The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long‐term clinical outcomes in patients with ulcerative colitis
Alimentary Pharmacology & Therapeutics2023Vol. 59(1), pp. 64–70
Citations Over TimeTop 10% of 2023 papers
Abstract
The MMES exhibited a benefit in predicting long-term outcome in UC even though endoscopic improvement remains the strongest predictor.
Related Papers
- → Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006(2007)116 cited
- → Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis(2010)71 cited
- → Utilization and surgical procedures following Colectomy in patients with Ulcerative Colitis(2009)
- → 21 NATURAL HISTORY OF COLECTOMY AMONG HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS IN THE CONTEMPORARY ERA OF BIOLOGICS(2020)
- → Colectomy rates for ulcerative colitis over time: Navigating the evidence in the era of precision medicine and individualised treatment(2022)